China National Standard Pharmaceutical Corporation Limited (STD Pharm), headquartered in Huangshi, Hubei, with eight subsidiaries across Beijing, Shanghai, Shenzhen, Nanjing, Hubei and the United States, is a globally recognized provider of small-molecule standard substances for biochemical research. The company offers custom synthesis, analysis, inspection and verification of biological and chemical drug standards, impurity controls, pharmacopoeia standard solutions and national reference substances, with a catalog of over 2 million compound types and more than 1,000,000 stocked products, including leading brands such as USP, EP, BP, JP, LGC and TRC, serving over 10,000 biochemical and pharmaceutical research institutions across 100 countries. Every compound ships with a certificate of analysis backed by HPLC/GC, mass spectrometry and NMR data, with additional testing (elemental analysis, TGA, IR, UV, and various NMR modes) available on request, supported by large inventory centers in both China and the US for rapid global fulfillment. The company holds ISO 9001:2015, ISO/IEC 17025:2017 and ISO 17034:2016 certifications and offers OEM, ODM and own-brand manufacturing plus CMO and CDMO contract services, with roughly 30% of sales exported and 70% domestic, shipping under FOB, CIF, EXW, CIP, FCA or CPT terms with payment via T/T.
コメントはありません。
評価とコメントを残す